Ivan Maillard - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ivan Maillard

Showing results (171-180 of 173) with videos related to

Pageof 18

Sort By:

You have reached the last page of results.This site can display upto 173 results.

JCO Oncology Practice|June 16, 2021

SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed TherapyLova Sun, Sanjna Surya, Noah G Goodman, et al.

Medrxiv : the Preprint Server for Health Sciences|January 20, 2021

SARS-CoV-2 seropositivity and seroconversion in patients undergoing active cancer-directed therapyLova Sun, Sanjna Surya, Noah G Goodman, et al.

Blood|December 10, 2025

CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosisJoseph M Rocco, Joseph H Oved, Rikita J Patel, et al.

Pageof 18

Search research articles

Showing results (171-180 of 173) with videos related to

Sort By:

Pageof 18

You have reached the last page of results.This site can display upto 173 results.

JCO Oncology Practice|June 16, 2021

SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed TherapyLova Sun, Sanjna Surya, Noah G Goodman, et al.

Medrxiv : the Preprint Server for Health Sciences|January 20, 2021

SARS-CoV-2 seropositivity and seroconversion in patients undergoing active cancer-directed therapyLova Sun, Sanjna Surya, Noah G Goodman, et al.

Blood|December 10, 2025

CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosisJoseph M Rocco, Joseph H Oved, Rikita J Patel, et al.

Pageof 18